Genmab A/S announced today that the European Commission (EC) has granted marketing authorization for TIVDAK® (tisotumab vedotin), an antibody-drug conjugate (ADC), as monotherapy treatment for adult ...
Medically reviewed by Daniel More, MD Allergies occur when your immune system overreacts to allergens like pet dander, pollen ...
BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...
A 59-year-old British woman preparing for the funeral of her mother who died of breast cancer was diagnosed with the same disease within a week. According to Sue, she had first noticed redness and ...